The week in health tech, explained in plain English.Get the free newsletter →
November 2, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

How Health Plans Tell If Their Payment Ops Can Scale

Payment operations are an overlooked stress test for health plans. When volume triples, driven by membership growth, new lines of business, or value-based contracts, the plumbing behind provider and member payments either holds or buckles. A piece in Healthcare Dive argues that three metrics expose the difference: exception volume, return rate, and digital payment share.

The distinction is between buying capacity and buying architecture. Capacity means throwing more staff, manual reconciliation, and workarounds at rising transaction counts. That approach shows up as exceptions and returns that climb in step with volume, because every edge case still needs a human. Architecture means automated, digital-first payment systems where straight-through processing absorbs growth without a proportional rise in errors or rework.

For payer executives, the practical read is simple. If return rates and manual exceptions spike as volume grows, the operation was never built to scale. A high and stable digital payment share signals the opposite. The stakes include provider satisfaction, cash flow, and the administrative cost that eats into margins.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.